{
    "xml": "<topic id=\"PHP2713\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/fentanyl\" basename=\"fentanyl\" title=\"FENTANYL\">\n<title>FENTANYL</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_95\" namespace=\"/interactions/list-of-drug-interactions/analgesics/opioid-analgesics/fentanyl\">Fentanyl</xref>\n</p>\n<data name=\"vtmid\">40648001</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_110392128\" title=\"Opioids\">Opioids</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34573\" title=\"OPIOIDS\" namespace=\"/drug-classes/opioids\">OPIOIDS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP68849\" outputclass=\"indicationsAndDose\" rev=\"1.51\" parent=\"/drugs/fentanyl\">\n<title>Indications and dose</title>\n<body>\r\n<section outputclass=\"indicationAndDoseGroup\">\r\n<sectiondiv outputclass=\"therapeuticIndications\">\r\n<p outputclass=\"therapeuticIndication\">Chronic intractable pain not currently treated with a strong opioid analgesic</p>\n</sectiondiv>\r\n<p outputclass=\"routesOfAdministration\">By transdermal application</p>\r\n<ul outputclass=\"patientGroups\">\r\n<li outputclass=\"patientGroup child\">\r\n<p>Child 16&#8211;17 years</p>\r\n<p>Initially 12&#8239;micrograms/hour every 72&#8239;hours, alternatively initially 25&#8239;micrograms/hour every 72&#8239;hours, when starting, evaluation of the analgesic effect should not be made before the system has been worn for 24 hours (to allow for the gradual increase in plasma-fentanyl concentration)&#8212;previous analgesic therapy should be phased out gradually from time of first patch application, dose should be adjusted at 48&#8211;72 hour intervals in steps of 12&#8211;25&#8239;micrograms/hour if necessary, more than one patch may be used at a time (but applied at the same time to avoid confusion)&#8212;consider additional or alternative analgesic therapy if dose required exceeds 300&#8239;micrograms/hour (important: it takes 17 hours or more for the plasma-fentanyl concentration to decrease by 50%&#8212; replacement opioid therapy should be initiated at a low dose and increased gradually).</p>\n</li>\r\n<li outputclass=\"patientGroup adult\">\r\n<p>Adult</p>\r\n<p>Initially 12&#8239;micrograms/hour every 72&#8239;hours, alternatively initially 25&#8239;micrograms/hour every 72&#8239;hours, when starting, evaluation of the analgesic effect should not be made before the system has been worn for 24 hours (to allow for the gradual increase in plasma-fentanyl concentration)&#8212;previous analgesic therapy should be phased out gradually from time of first patch application, dose should be adjusted at 48&#8211;72 hour intervals in steps of 12&#8211;25&#8239;micrograms/hour if necessary, more than one patch may be used at a time (but applied at the same time to avoid confusion)&#8212;consider additional or alternative analgesic therapy if dose required exceeds 300&#8239;micrograms/hour (important: it takes 17 hours or more for the plasma-fentanyl concentration to decrease by 50%&#8212; replacement opioid therapy should be initiated at a low dose and increased gradually).</p>\n</li>\r\n</ul>\n</section>\r\n<section outputclass=\"indicationAndDoseGroup\">\r\n<sectiondiv outputclass=\"therapeuticIndications\">\r\n<p outputclass=\"therapeuticIndication\">Chronic intractable pain currently treated with a strong opioid analgesic</p>\n</sectiondiv>\r\n<p outputclass=\"routesOfAdministration\">By transdermal application</p>\r\n<ul outputclass=\"patientGroups\">\r\n<li outputclass=\"patientGroup child\">\r\n<p>Child 2&#8211;17 years</p>\r\n<p>Initial dose based on previous 24-hour opioid requirement (consult product literature), for evaluating analgesic efficacy and dose increments, see under <i>Chronic intractable pain not currently treated with a strong opioid analgesic</i>, for conversion from long term oral morphine to transdermal fentanyl, see <i>Pain management with opioids</i> under <xref format=\"dita\" href=\"#PHP107735\" type=\"bookmark\" namespace=\"/guidance/prescribing-in-palliative-care\">Prescribing in palliative care</xref>.</p>\n</li>\r\n<li outputclass=\"patientGroup adult\">\r\n<p>Adult</p>\r\n<p>Initial dose based on previous 24-hour opioid requirement (consult product literature), for evaluating analgesic efficacy and dose increments, see under <i>Chronic intractable pain not currently treated with a strong opioid analgesic</i>, for conversion from long term oral morphine to transdermal fentanyl, see <i>Pain management with opioids</i> under <xref format=\"dita\" href=\"#PHP107735\" type=\"bookmark\" namespace=\"/guidance/prescribing-in-palliative-care\">Prescribing in palliative care</xref>.</p>\n</li>\r\n</ul>\n</section>\r\n<section outputclass=\"indicationAndDoseGroup\">\r\n<sectiondiv outputclass=\"therapeuticIndications\">\r\n<p outputclass=\"therapeuticIndication\">Spontaneous respiration: analgesia and enhancement of anaesthesia, during operation</p>\n</sectiondiv>\r\n<p outputclass=\"routesOfAdministration\">By slow intravenous injection</p>\r\n<ul outputclass=\"patientGroups\">\r\n<li outputclass=\"patientGroup adult\">\r\n<p>Adult</p>\r\n<p>Initially 50&#8211;100&#8239;micrograms (max. per dose 200&#8239;micrograms), dose maximum on specialist advice, then 25&#8211;50&#8239;micrograms as required.</p>\n</li>\r\n</ul>\r\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\r\n<ul outputclass=\"patientGroups\">\r\n<li outputclass=\"patientGroup adult\">\r\n<p>Adult</p>\r\n<p>3&#8211;4.8&#8239;micrograms/kg/hour, adjusted according to response.</p>\n</li>\r\n</ul>\n</section>\r\n<section outputclass=\"indicationAndDoseGroup\">\r\n<sectiondiv outputclass=\"therapeuticIndications\">\r\n<p outputclass=\"therapeuticIndication\">Assisted ventilation: analgesia and enhancement of anaesthesia during operation</p>\n</sectiondiv>\r\n<p outputclass=\"routesOfAdministration\">By slow intravenous injection</p>\r\n<ul outputclass=\"patientGroups\">\r\n<li outputclass=\"patientGroup adult\">\r\n<p>Adult</p>\r\n<p>Initially 300&#8211;3500&#8239;micrograms, then 100&#8211;200&#8239;micrograms as required.</p>\n</li>\r\n</ul>\r\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\r\n<ul outputclass=\"patientGroups\">\r\n<li outputclass=\"patientGroup adult\">\r\n<p>Adult</p>\r\n<p>Initially 10&#8239;micrograms/kg, dose to be given over 10 minutes, then 6&#8239;micrograms/kg/hour, adjusted according to response, may require up to 180&#8239;micrograms/kg/hour during cardiac surgery.</p>\n</li>\r\n</ul>\n</section>\r\n<section outputclass=\"indicationAndDoseGroup\">\r\n<sectiondiv outputclass=\"therapeuticIndications\">\r\n<p outputclass=\"therapeuticIndication\">Assisted ventilation: analgesia and respiratory depression in intensive care</p>\n</sectiondiv>\r\n<p outputclass=\"routesOfAdministration\">By slow intravenous injection</p>\r\n<ul outputclass=\"patientGroups\">\r\n<li outputclass=\"patientGroup adult\">\r\n<p>Adult</p>\r\n<p>Initially 300&#8211;3500&#8239;micrograms, then 100&#8211;200&#8239;micrograms as required.</p>\n</li>\r\n</ul>\r\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\r\n<ul outputclass=\"patientGroups\">\r\n<li outputclass=\"patientGroup adult\">\r\n<p>Adult</p>\r\n<p>Initially 10&#8239;micrograms/kg, dose to be given over 10 minutes, then 6&#8239;micrograms/kg/hour, adjusted according to response, may require up to 180&#8239;micrograms/kg/hour during cardiac surgery.</p>\n</li>\r\n</ul>\n</section>\r\n<section outputclass=\"indicationAndDoseGroup\">\r\n<sectiondiv outputclass=\"therapeuticIndications\">\r\n<p outputclass=\"therapeuticIndication\">Breakthrough pain in patients receiving opioid therapy for chronic cancer pain</p>\n</sectiondiv>\r\n<p outputclass=\"routesOfAdministration\">Initially by buccal administration using lozenges</p>\r\n<ul outputclass=\"patientGroups\">\r\n<li outputclass=\"patientGroup child\">\r\n<p>Child 16&#8211;17 years</p>\r\n<p>Initially 200&#8239;micrograms, dose to be given over 15 minutes, then (by buccal administration) 200&#8239;micrograms after 15&#8239;minutes if required, no more than 2 dose units for each pain episode; if adequate pain relief not achieved with 1 dose unit for consecutive breakthrough pain episodes, increase the strength of the dose unit until adequate pain relief achieved with 4 lozenges or less daily, if more than 4 episodes of breakthrough pain each day, adjust background analgesia.</p>\n</li>\r\n<li outputclass=\"patientGroup adult\">\r\n<p>Adult</p>\r\n<p>Initially 200&#8239;micrograms, dose to be given over 15 minutes, then (by buccal administration) 200&#8239;micrograms after 15&#8239;minutes if required, no more than 2 dose units for each pain episode; if adequate pain relief not achieved with 1 dose unit for consecutive breakthrough pain episodes, increase the strength of the dose unit until adequate pain relief achieved with 4 lozenges or less daily, if more than 4 episodes of breakthrough pain each day, adjust background analgesia.</p>\n</li>\r\n</ul>\r\n<p outputclass=\"routesOfAdministration\">By buccal administration using buccal films</p>\r\n<ul outputclass=\"patientGroups\">\r\n<li outputclass=\"patientGroup adult\">\r\n<p>Adult</p>\r\n<p>Initially 200&#8239;micrograms, adjusted according to response, consult product literature for information on dose adjustments, maximum 1.2&#8239;mg per episode of breakthrough pain; leave at least 4 hours between treatment of episodes of breakthrough pain, if more than 4 episodes of breakthrough pain each day occur on more than 4 consecutive days, adjust background analgesia.</p>\n</li>\r\n</ul>\n</section>\r\n\r\n<section outputclass=\"extremesOfBodyWeight\">\r\n<title>Doses at extremes of body-weight</title>\r\n<p>To avoid excessive dosage in obese patients, dose may need to be calculated on the basis of ideal bodyweight.</p>\n</section>\r\n<section outputclass=\"doseEquivalence\">\r\n<title>Dose equivalence and conversion</title>\r\n<p>Fentanyl films are <b>not bioequivalent</b> to other fentanyl preparations.</p>\r\n<p>Fentanyl preparations for the treatment of breakthrough pain are not interchangeable; if patients are switched from another fentanyl-containing preparation, a new dose titration is required.</p>\n</section>\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP67445\" outputclass=\"unlicensedUse\" rev=\"1.8\" parent=\"/drugs/fentanyl\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>Not licensed for use in children under 2 years; infusion not licensed for use in children under 12 years.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP72099\" outputclass=\"cautions\" rev=\"1.26\" parent=\"/drugs/fentanyl\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<title>General cautions:</title>\n<p>\n<ph outputclass=\"caution\">Cerebral tumour</ph>; <ph outputclass=\"caution\">diabetes mellitus (with <i>Actiq</i>\n<tm tmtype=\"reg\"/> lozenges)</ph>; <ph outputclass=\"caution\">impaired consciousness</ph>\n</p>\n<sectiondiv outputclass=\"additionalCautions\">\n<p outputclass=\"title\">Specific cautions:</p>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With buccal use</p>\n<p>\n<ph outputclass=\"caution\">mucositis&#8212;absorption from oral preparations may be increased, caution during dose titration</ph> (in adults)</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">transdermal</ph> use</p>\n<p outputclass=\"title\">Transdermal preparations</p>\n<p>Transdermal fentanyl patches) are not suitable for acute pain or in those patients whose analgesic requirements are changing rapidly because the long time to steady state prevents rapid titration of the dose.</p>\n<p>Risk of fatal respiratory depression, particularly in patients not previously treated with a strong opioid analgesic; manufacturer recommends use only in opioid tolerant patients.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p outputclass=\"title\">Repeated intra-operative doses</p>\n<p>Repeated intra-operative doses should be given with care since the resulting respiratory depression can persist postoperatively and occasionally it may become apparent for the first time postoperatively when monitoring of the patient might be less intensive.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67941\" outputclass=\"sideEffects\" rev=\"1.27\" parent=\"/drugs/fentanyl\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<title>General side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">aesthenia</ph>; <ph outputclass=\"sideEffect\">anorexia</ph>; <ph outputclass=\"sideEffect\">anxiety</ph>; <ph outputclass=\"sideEffect\">appetite changes</ph>; <ph outputclass=\"sideEffect\">application-site reactions</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">dyspnoea</ph>; <ph outputclass=\"sideEffect\">gastro-oesophageal reflux disease</ph>; <ph outputclass=\"sideEffect\">hypertension</ph>; <ph outputclass=\"sideEffect\">myoclonus</ph>; <ph outputclass=\"sideEffect\">paraesthesia</ph>; <ph outputclass=\"sideEffect\">pharyngitis</ph>; <ph outputclass=\"sideEffect\">rhinitis</ph>; <ph outputclass=\"sideEffect\">stomatitis</ph>; <ph outputclass=\"sideEffect\">tremor</ph>; <ph outputclass=\"sideEffect\">vasodilation</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Amnesia</ph>; <ph outputclass=\"sideEffect\">arthralgia</ph>; <ph outputclass=\"sideEffect\">blood disorders</ph>; <ph outputclass=\"sideEffect\">chills</ph>; <ph outputclass=\"sideEffect\">depressed level of consciousness</ph>; <ph outputclass=\"sideEffect\">dysgeusia</ph>; <ph outputclass=\"sideEffect\">flatulence</ph>; <ph outputclass=\"sideEffect\">hypoventilation</ph>; <ph outputclass=\"sideEffect\">ileus</ph>; <ph outputclass=\"sideEffect\">impaired concentration</ph>; <ph outputclass=\"sideEffect\">impaired coordination</ph>; <ph outputclass=\"sideEffect\">loss of consciousness</ph>; <ph outputclass=\"sideEffect\">malaise</ph>; <ph outputclass=\"sideEffect\">parosmia</ph>; <ph outputclass=\"sideEffect\">pyrexia</ph>; <ph outputclass=\"sideEffect\">seizures</ph>; <ph outputclass=\"sideEffect\">speech disorder</ph>; <ph outputclass=\"sideEffect\">thirst</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Hiccups</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Apnoea</ph>; <ph outputclass=\"sideEffect\">arrhythmia</ph>; <ph outputclass=\"sideEffect\">ataxia</ph>; <ph outputclass=\"sideEffect\">bladder pain</ph>; <ph outputclass=\"sideEffect\">delusions</ph>; <ph outputclass=\"sideEffect\">haemoptysis</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"specificSideEffects\">\n<title>Specific side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"sideEffect\">myoclonic movements</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"sideEffect\">laryngospasm</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"sideEffect\">asystole</ph>; <ph outputclass=\"sideEffect\">insomnia</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">transdermal</ph> use</p>\n<p outputclass=\"title\">Fever or external heat</p>\n<p>Monitor patients using patches for increased side-effects if fever present (increased absorption possible); avoid exposing application site to external heat, for example a hot bath or sauna (may also increase absorption).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p outputclass=\"title\">Muscle rigidity</p>\n<p>Fentanyl can cause muscle rigidity, particularly of the chest wall or jaw; this can be managed by the use of neuromuscular blocking drugs.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP72203\" outputclass=\"breastFeeding\" parent=\"/drugs/fentanyl\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Monitor infant for opioid-induced side-effects.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP68297\" outputclass=\"renalImpairment\" parent=\"/drugs/fentanyl\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid use or reduce dose; opioid effects increased and prolonged and increased cerebral sensitivity occurs.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP72446\" outputclass=\"directionsForAdministration\" rev=\"1.26\" parent=\"/drugs/fentanyl\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">transdermal</ph> use</p>\n<p>For <i>patches</i>, apply to dry, non-irritated, non-irradiated, non-hairy skin on torso or upper arm, removing after 72&#8239;hours and siting replacement patch on a different area (avoid using the same area for several days).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>For <i>intravenous infusion</i>, injection solution may be diluted in Glucose 5% or Sodium Chloride 0.9%.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>For <i>intravenous infusion</i>(<i>Sublimaze</i>), give continuously or intermittently in Glucose 5% or Sodium Chloride 0.9%.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">buccal</ph> use in adults</p>\n<p>For buccal films, moisten mouth, place film on inner lining of cheek (pink side to cheek), hold for at least 5&#8239;seconds until it sticks, and leave to dissolve (15&#8211;30 minutes); if more than 1 film required do not overlap, but use another area of the mouth. Avoid liquids for 5&#8239;minutes after application; avoid food until the film has dissolved.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">buccal</ph> use</p>\n<p>Patients should be advised to place the lozenge in the mouth against the cheek and move it around the mouth using the applicator; each lozenge should be sucked over a 15&#8239;minute period. In patients with a dry mouth, water may be used to moisten the buccal mucosa. Patients with diabetes should be advised each lozenge contains approximately 2&#8239;g glucose.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57542\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.18\" parent=\"/drugs/fentanyl\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">transdermal</ph> use</p>\n<p>Prescriptions for fentanyl patches can be written to show the strength in terms of the release rate and it is acceptable to write <i>'Fentanyl 25 patches</i>&#8216; to prescribe patches that release fentanyl 25&#8239;micrograms per hour. The dosage should be expressed in terms of the interval between applying a patch and replacing it with a new one, e.g. <i>'one patch to be applied every 72 hours'</i>. The total quantity of patches to be supplied should be written in words and figures.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP68514\" outputclass=\"patientAndCarerAdvice\" rev=\"1.33\" parent=\"/drugs/fentanyl\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Fentanyl lozenges for pain</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/fentanyl-lozenges-for-pain\">www.medicinesforchildren.org.uk/fentanyl-lozenges-for-pain</xref>\n</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Fentanyl patches for pain</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/fentanyl-patches-for-pain\">www.medicinesforchildren.org.uk/fentanyl-patches-for-pain</xref>\n</p>\n</sectiondiv>\n</section>\r\n<section outputclass=\"generalPatientAdvice\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">transdermal</ph> use</p>\r\n<p>Patients and carers should be informed about safe use, including correct administration and disposal, strict adherence to dosage instructions, and the symptoms and signs of opioid overdosage.</p>\r\n<p>Patches should be removed immediately in case of breathing difficulties, marked drowsiness, confusion, dizziness, or impaired speech, and patients and carers should seek prompt medical attention.</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">buccal</ph> use in adults</p>\r\n<p>Patients or carers should be given advice on how to administer fentanyl buccal films or fentanyl lozenges.</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intranasal</ph> use in adults</p>\r\n<p>Patients or carers should be given advice on how to administer fentanyl nasal spray.</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP2713-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/fentanyl\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: solution for injection, solution for infusion, infusion</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77128\" title=\"Sublingual tablet\" namespace=\"/drugs/fentanyl/sublingual-tablet\">Sublingual tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77070\" title=\"Buccal tablet\" namespace=\"/drugs/fentanyl/buccal-tablet\">Buccal tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77107\" title=\"Buccal film\" namespace=\"/drugs/fentanyl/buccal-film\">Buccal film</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77055\" title=\"Lozenge\" namespace=\"/drugs/fentanyl/lozenge\">Lozenge</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77090\" title=\"Solution for injection\" namespace=\"/drugs/fentanyl/solution-for-injection\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77100\" title=\"Solution for infusion\" namespace=\"/drugs/fentanyl/solution-for-infusion\">Solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77115\" title=\"Transdermal patch\" namespace=\"/drugs/fentanyl/transdermal-patch\">Transdermal patch</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77076\" title=\"Spray\" namespace=\"/drugs/fentanyl/spray\">Spray</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP88071\" namespace=\"/drugs/bupivacaine-with-fentanyl\" title=\"BUPIVACAINE WITH FENTANYL\" count=\"1\" rel=\"backlink\">BUPIVACAINE WITH FENTANYL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78500\" namespace=\"/treatment-summaries/pre-medication-and-peri-operative-drugs\" title=\"Pre-medication and peri-operative drugs\" count=\"4\" rel=\"backlink\">Pre-medication and peri-operative drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78520\" namespace=\"/treatment-summaries/analgesics\" title=\"Analgesics\" count=\"2\" rel=\"backlink\">Analgesics</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_95\" namespace=\"/interactions/list-of-drug-interactions/analgesics/opioid-analgesics/fentanyl\" title=\"Fentanyl\" count=\"1\" rel=\"link\">Fentanyl</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34573\" namespace=\"/drug-classes/opioids\" title=\"OPIOIDS\" count=\"1\" rel=\"link\">OPIOIDS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP107735\" namespace=\"/guidance/prescribing-in-palliative-care\" title=\"Prescribing in palliative care\" count=\"2\" rel=\"link\">Prescribing in palliative care</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77128\" namespace=\"/drugs/fentanyl/sublingual-tablet\" title=\"Sublingual tablet\" count=\"1\" rel=\"link\">Sublingual tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77070\" namespace=\"/drugs/fentanyl/buccal-tablet\" title=\"Buccal tablet\" count=\"1\" rel=\"link\">Buccal tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77107\" namespace=\"/drugs/fentanyl/buccal-film\" title=\"Buccal film\" count=\"1\" rel=\"link\">Buccal film</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77055\" namespace=\"/drugs/fentanyl/lozenge\" title=\"Lozenge\" count=\"1\" rel=\"link\">Lozenge</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77090\" namespace=\"/drugs/fentanyl/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77100\" namespace=\"/drugs/fentanyl/solution-for-infusion\" title=\"Solution for infusion\" count=\"1\" rel=\"link\">Solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77115\" namespace=\"/drugs/fentanyl/transdermal-patch\" title=\"Transdermal patch\" count=\"1\" rel=\"link\">Transdermal patch</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77076\" namespace=\"/drugs/fentanyl/spray\" title=\"Spray\" count=\"1\" rel=\"link\">Spray</xref>\n</links>\n</topic>",
    "id": "PHP2713",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/fentanyl",
    "basename": "fentanyl",
    "title": "FENTANYL",
    "interactants": [
        {
            "id": "bnf_int_95",
            "label": "Fentanyl"
        }
    ],
    "vtmid": "40648001",
    "drugClassification": [
        "Opioids"
    ],
    "inheritsFromClass": [
        "OPIOIDS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Chronic intractable pain not currently treated with a strong opioid analgesic",
                        "html": "Chronic intractable pain not currently treated with a strong opioid analgesic"
                    }
                ],
                "specificity": {
                    "routes": [
                        "transdermal application"
                    ],
                    "textContent": "By transdermal application",
                    "html": "By transdermal application"
                },
                "child": [
                    {
                        "textContent": "Initially 12 micrograms/hour every 72 hours, alternatively initially 25 micrograms/hour every 72 hours, when starting, evaluation of the analgesic effect should not be made before the system has been worn for 24 hours (to allow for the gradual increase in plasma-fentanyl concentration)&#8212;previous analgesic therapy should be phased out gradually from time of first patch application, dose should be adjusted at 48&#8211;72 hour intervals in steps of 12&#8211;25 micrograms/hour if necessary, more than one patch may be used at a time (but applied at the same time to avoid confusion)&#8212;consider additional or alternative analgesic therapy if dose required exceeds 300 micrograms/hour (important: it takes 17 hours or more for the plasma-fentanyl concentration to decrease by 50%&#8212; replacement opioid therapy should be initiated at a low dose and increased gradually).",
                        "html": "<p>Initially 12&#8239;micrograms/hour every 72&#8239;hours, alternatively initially 25&#8239;micrograms/hour every 72&#8239;hours, when starting, evaluation of the analgesic effect should not be made before the system has been worn for 24 hours (to allow for the gradual increase in plasma-fentanyl concentration)&#8212;previous analgesic therapy should be phased out gradually from time of first patch application, dose should be adjusted at 48&#8211;72 hour intervals in steps of 12&#8211;25&#8239;micrograms/hour if necessary, more than one patch may be used at a time (but applied at the same time to avoid confusion)&#8212;consider additional or alternative analgesic therapy if dose required exceeds 300&#8239;micrograms/hour (important: it takes 17 hours or more for the plasma-fentanyl concentration to decrease by 50%&#8212; replacement opioid therapy should be initiated at a low dose and increased gradually).</p>",
                        "ageGroup": "16&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 12 micrograms/hour every 72 hours, alternatively initially 25 micrograms/hour every 72 hours, when starting, evaluation of the analgesic effect should not be made before the system has been worn for 24 hours (to allow for the gradual increase in plasma-fentanyl concentration)&#8212;previous analgesic therapy should be phased out gradually from time of first patch application, dose should be adjusted at 48&#8211;72 hour intervals in steps of 12&#8211;25 micrograms/hour if necessary, more than one patch may be used at a time (but applied at the same time to avoid confusion)&#8212;consider additional or alternative analgesic therapy if dose required exceeds 300 micrograms/hour (important: it takes 17 hours or more for the plasma-fentanyl concentration to decrease by 50%&#8212; replacement opioid therapy should be initiated at a low dose and increased gradually).",
                        "html": "<p>Initially 12&#8239;micrograms/hour every 72&#8239;hours, alternatively initially 25&#8239;micrograms/hour every 72&#8239;hours, when starting, evaluation of the analgesic effect should not be made before the system has been worn for 24 hours (to allow for the gradual increase in plasma-fentanyl concentration)&#8212;previous analgesic therapy should be phased out gradually from time of first patch application, dose should be adjusted at 48&#8211;72 hour intervals in steps of 12&#8211;25&#8239;micrograms/hour if necessary, more than one patch may be used at a time (but applied at the same time to avoid confusion)&#8212;consider additional or alternative analgesic therapy if dose required exceeds 300&#8239;micrograms/hour (important: it takes 17 hours or more for the plasma-fentanyl concentration to decrease by 50%&#8212; replacement opioid therapy should be initiated at a low dose and increased gradually).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Chronic intractable pain currently treated with a strong opioid analgesic",
                        "html": "Chronic intractable pain currently treated with a strong opioid analgesic"
                    }
                ],
                "specificity": {
                    "routes": [
                        "transdermal application"
                    ],
                    "textContent": "By transdermal application",
                    "html": "By transdermal application"
                },
                "child": [
                    {
                        "textContent": "Initial dose based on previous 24-hour opioid requirement (consult product literature), for evaluating analgesic efficacy and dose increments, see under Chronic intractable pain not currently treated with a strong opioid analgesic, for conversion from long term oral morphine to transdermal fentanyl, see Pain management with opioids under Prescribing in palliative care.",
                        "html": "<p>Initial dose based on previous 24-hour opioid requirement (consult product literature), for evaluating analgesic efficacy and dose increments, see under <i>Chronic intractable pain not currently treated with a strong opioid analgesic</i>, for conversion from long term oral morphine to transdermal fentanyl, see <i>Pain management with opioids</i> under <xref format=\"dita\" href=\"#PHP107735\" type=\"bookmark\" namespace=\"/guidance/prescribing-in-palliative-care\">Prescribing in palliative care</xref>.</p>",
                        "ageGroup": "2&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initial dose based on previous 24-hour opioid requirement (consult product literature), for evaluating analgesic efficacy and dose increments, see under Chronic intractable pain not currently treated with a strong opioid analgesic, for conversion from long term oral morphine to transdermal fentanyl, see Pain management with opioids under Prescribing in palliative care.",
                        "html": "<p>Initial dose based on previous 24-hour opioid requirement (consult product literature), for evaluating analgesic efficacy and dose increments, see under <i>Chronic intractable pain not currently treated with a strong opioid analgesic</i>, for conversion from long term oral morphine to transdermal fentanyl, see <i>Pain management with opioids</i> under <xref format=\"dita\" href=\"#PHP107735\" type=\"bookmark\" namespace=\"/guidance/prescribing-in-palliative-care\">Prescribing in palliative care</xref>.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Spontaneous respiration: analgesia and enhancement of anaesthesia, during operation",
                        "html": "Spontaneous respiration: analgesia and enhancement of anaesthesia, during operation"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 50&#8211;100 micrograms (max. per dose 200 micrograms), dose maximum on specialist advice, then 25&#8211;50 micrograms as required.",
                        "html": "<p>Initially 50&#8211;100&#8239;micrograms (max. per dose 200&#8239;micrograms), dose maximum on specialist advice, then 25&#8211;50&#8239;micrograms as required.</p>"
                    },
                    {
                        "textContent": "3&#8211;4.8 micrograms/kg/hour, adjusted according to response.",
                        "html": "<p>3&#8211;4.8&#8239;micrograms/kg/hour, adjusted according to response.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Assisted ventilation: analgesia and enhancement of anaesthesia during operation",
                        "html": "Assisted ventilation: analgesia and enhancement of anaesthesia during operation"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 300&#8211;3500 micrograms, then 100&#8211;200 micrograms as required.",
                        "html": "<p>Initially 300&#8211;3500&#8239;micrograms, then 100&#8211;200&#8239;micrograms as required.</p>"
                    },
                    {
                        "textContent": "Initially 10 micrograms/kg, dose to be given over 10 minutes, then 6 micrograms/kg/hour, adjusted according to response, may require up to 180 micrograms/kg/hour during cardiac surgery.",
                        "html": "<p>Initially 10&#8239;micrograms/kg, dose to be given over 10 minutes, then 6&#8239;micrograms/kg/hour, adjusted according to response, may require up to 180&#8239;micrograms/kg/hour during cardiac surgery.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Assisted ventilation: analgesia and respiratory depression in intensive care",
                        "html": "Assisted ventilation: analgesia and respiratory depression in intensive care"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 300&#8211;3500 micrograms, then 100&#8211;200 micrograms as required.",
                        "html": "<p>Initially 300&#8211;3500&#8239;micrograms, then 100&#8211;200&#8239;micrograms as required.</p>"
                    },
                    {
                        "textContent": "Initially 10 micrograms/kg, dose to be given over 10 minutes, then 6 micrograms/kg/hour, adjusted according to response, may require up to 180 micrograms/kg/hour during cardiac surgery.",
                        "html": "<p>Initially 10&#8239;micrograms/kg, dose to be given over 10 minutes, then 6&#8239;micrograms/kg/hour, adjusted according to response, may require up to 180&#8239;micrograms/kg/hour during cardiac surgery.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Breakthrough pain in patients receiving opioid therapy for chronic cancer pain",
                        "html": "Breakthrough pain in patients receiving opioid therapy for chronic cancer pain"
                    }
                ],
                "specificity": {
                    "routes": [
                        "buccal administration using buccal films"
                    ],
                    "textContent": "By buccal administration using buccal films",
                    "html": "By buccal administration using buccal films"
                },
                "child": [
                    {
                        "textContent": "Initially 200 micrograms, dose to be given over 15 minutes, then (by buccal administration) 200 micrograms after 15 minutes if required, no more than 2 dose units for each pain episode; if adequate pain relief not achieved with 1 dose unit for consecutive breakthrough pain episodes, increase the strength of the dose unit until adequate pain relief achieved with 4 lozenges or less daily, if more than 4 episodes of breakthrough pain each day, adjust background analgesia.",
                        "html": "<p>Initially 200&#8239;micrograms, dose to be given over 15 minutes, then (by buccal administration) 200&#8239;micrograms after 15&#8239;minutes if required, no more than 2 dose units for each pain episode; if adequate pain relief not achieved with 1 dose unit for consecutive breakthrough pain episodes, increase the strength of the dose unit until adequate pain relief achieved with 4 lozenges or less daily, if more than 4 episodes of breakthrough pain each day, adjust background analgesia.</p>",
                        "ageGroup": "16&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 200 micrograms, dose to be given over 15 minutes, then (by buccal administration) 200 micrograms after 15 minutes if required, no more than 2 dose units for each pain episode; if adequate pain relief not achieved with 1 dose unit for consecutive breakthrough pain episodes, increase the strength of the dose unit until adequate pain relief achieved with 4 lozenges or less daily, if more than 4 episodes of breakthrough pain each day, adjust background analgesia.",
                        "html": "<p>Initially 200&#8239;micrograms, dose to be given over 15 minutes, then (by buccal administration) 200&#8239;micrograms after 15&#8239;minutes if required, no more than 2 dose units for each pain episode; if adequate pain relief not achieved with 1 dose unit for consecutive breakthrough pain episodes, increase the strength of the dose unit until adequate pain relief achieved with 4 lozenges or less daily, if more than 4 episodes of breakthrough pain each day, adjust background analgesia.</p>"
                    },
                    {
                        "textContent": "Initially 200 micrograms, adjusted according to response, consult product literature for information on dose adjustments, maximum 1.2 mg per episode of breakthrough pain; leave at least 4 hours between treatment of episodes of breakthrough pain, if more than 4 episodes of breakthrough pain each day occur on more than 4 consecutive days, adjust background analgesia.",
                        "html": "<p>Initially 200&#8239;micrograms, adjusted according to response, consult product literature for information on dose adjustments, maximum 1.2&#8239;mg per episode of breakthrough pain; leave at least 4 hours between treatment of episodes of breakthrough pain, if more than 4 episodes of breakthrough pain each day occur on more than 4 consecutive days, adjust background analgesia.</p>"
                    }
                ]
            }
        ],
        "extremesOfBodyWeight": [
            {
                "type": "extremesOfBodyWeight",
                "title": "Doses at extremes of body-weight",
                "textContent": "To avoid excessive dosage in obese patients, dose may need to be calculated on the basis of ideal bodyweight.",
                "html": "<p>To avoid excessive dosage in obese patients, dose may need to be calculated on the basis of ideal bodyweight.</p>"
            }
        ],
        "doseEquivalence": [
            {
                "type": "doseEquivalence",
                "title": "Dose equivalence and conversion",
                "textContent": "Fentanyl films are not bioequivalent to other fentanyl preparations.\n\nFentanyl preparations for the treatment of breakthrough pain are not interchangeable; if patients are switched from another fentanyl-containing preparation, a new dose titration is required.",
                "html": "<p>Fentanyl films are <b>not bioequivalent</b> to other fentanyl preparations.</p><p>Fentanyl preparations for the treatment of breakthrough pain are not interchangeable; if patients are switched from another fentanyl-containing preparation, a new dose titration is required.</p>"
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Not licensed for use in children under 2 years; infusion not licensed for use in children under 12 years.",
                "html": "<p>Not licensed for use in children under 2 years; infusion not licensed for use in children under 12 years.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Cerebral tumour",
                "html": "Cerebral tumour"
            },
            {
                "type": "cautions",
                "textContent": "diabetes mellitus (with Actiq lozenges)",
                "html": "diabetes mellitus (with <i>Actiq</i> <tm tmtype=\"reg\"/> lozenges)"
            },
            {
                "type": "cautions",
                "textContent": "impaired consciousness",
                "html": "impaired consciousness"
            }
        ],
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "mucositis&#8212;absorption from oral preparations may be increased, caution during dose titration in adults",
                "html": "mucositis&#8212;absorption from oral preparations may be increased, caution during dose titration in adults",
                "specificity": {
                    "textContent": "With buccal use",
                    "html": "With buccal use",
                    "routes": [
                        "buccal"
                    ],
                    "patientType": "adults"
                }
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "specificity": {
                    "textContent": "With transdermal use",
                    "html": "With <ph outputclass=\"route\">transdermal</ph> use",
                    "routes": [
                        "transdermal"
                    ]
                },
                "title": "Transdermal preparations",
                "textContent": "Transdermal fentanyl patches) are not suitable for acute pain or in those patients whose analgesic requirements are changing rapidly because the long time to steady state prevents rapid titration of the dose.\n\nRisk of fatal respiratory depression, particularly in patients not previously treated with a strong opioid analgesic; manufacturer recommends use only in opioid tolerant patients.",
                "html": "<p>Transdermal fentanyl patches) are not suitable for acute pain or in those patients whose analgesic requirements are changing rapidly because the long time to steady state prevents rapid titration of the dose.</p><p>Risk of fatal respiratory depression, particularly in patients not previously treated with a strong opioid analgesic; manufacturer recommends use only in opioid tolerant patients.</p>"
            },
            {
                "type": "importantAdvice",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "title": "Repeated intra-operative doses",
                "textContent": "Repeated intra-operative doses should be given with care since the resulting respiratory depression can persist postoperatively and occasionally it may become apparent for the first time postoperatively when monitoring of the patient might be less intensive.",
                "html": "<p>Repeated intra-operative doses should be given with care since the resulting respiratory depression can persist postoperatively and occasionally it may become apparent for the first time postoperatively when monitoring of the patient might be less intensive.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "aesthenia",
                        "html": "aesthenia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "anorexia",
                        "html": "anorexia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "anxiety",
                        "html": "anxiety",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "appetite changes",
                        "html": "appetite changes",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "application-site reactions",
                        "html": "application-site reactions",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dyspepsia",
                        "html": "dyspepsia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dyspnoea",
                        "html": "dyspnoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "gastro-oesophageal reflux disease",
                        "html": "gastro-oesophageal reflux disease",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hypertension",
                        "html": "hypertension",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "myoclonus",
                        "html": "myoclonus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "paraesthesia",
                        "html": "paraesthesia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pharyngitis",
                        "html": "pharyngitis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rhinitis",
                        "html": "rhinitis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "stomatitis",
                        "html": "stomatitis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "tremor",
                        "html": "tremor",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vasodilation",
                        "html": "vasodilation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Amnesia",
                        "html": "Amnesia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "arthralgia",
                        "html": "arthralgia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "blood disorders",
                        "html": "blood disorders",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "chills",
                        "html": "chills",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "depressed level of consciousness",
                        "html": "depressed level of consciousness",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "dysgeusia",
                        "html": "dysgeusia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "flatulence",
                        "html": "flatulence",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hypoventilation",
                        "html": "hypoventilation",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "ileus",
                        "html": "ileus",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "impaired concentration",
                        "html": "impaired concentration",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "impaired coordination",
                        "html": "impaired coordination",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "loss of consciousness",
                        "html": "loss of consciousness",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "malaise",
                        "html": "malaise",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "parosmia",
                        "html": "parosmia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "pyrexia",
                        "html": "pyrexia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "seizures",
                        "html": "seizures",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "speech disorder",
                        "html": "speech disorder",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "thirst",
                        "html": "thirst",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Hiccups",
                        "html": "Hiccups",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Apnoea",
                        "html": "Apnoea",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "arrhythmia",
                        "html": "arrhythmia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "ataxia",
                        "html": "ataxia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "bladder pain",
                        "html": "bladder pain",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "delusions",
                        "html": "delusions",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "haemoptysis",
                        "html": "haemoptysis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ]
            }
        },
        "specific": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "myoclonic movements",
                        "html": "myoclonic movements",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "laryngospasm",
                        "html": "laryngospasm",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "asystole",
                        "html": "asystole",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "insomnia",
                        "html": "insomnia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "specificity": {
                    "textContent": "With transdermal use",
                    "html": "With <ph outputclass=\"route\">transdermal</ph> use",
                    "routes": [
                        "transdermal"
                    ]
                },
                "title": "Fever or external heat",
                "textContent": "Monitor patients using patches for increased side-effects if fever present (increased absorption possible); avoid exposing application site to external heat, for example a hot bath or sauna (may also increase absorption).",
                "html": "<p>Monitor patients using patches for increased side-effects if fever present (increased absorption possible); avoid exposing application site to external heat, for example a hot bath or sauna (may also increase absorption).</p>"
            },
            {
                "type": "advice",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "title": "Muscle rigidity",
                "textContent": "Fentanyl can cause muscle rigidity, particularly of the chest wall or jaw; this can be managed by the use of neuromuscular blocking drugs.",
                "html": "<p>Fentanyl can cause muscle rigidity, particularly of the chest wall or jaw; this can be managed by the use of neuromuscular blocking drugs.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Monitor infant for opioid-induced side-effects.",
                "html": "<p>Monitor infant for opioid-induced side-effects.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid use or reduce dose; opioid effects increased and prolonged and increased cerebral sensitivity occurs.",
                "html": "<p>Avoid use or reduce dose; opioid effects increased and prolonged and increased cerebral sensitivity occurs.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With transdermal use",
                    "html": "With <ph outputclass=\"route\">transdermal</ph> use",
                    "routes": [
                        "transdermal"
                    ]
                },
                "textContent": "For patches, apply to dry, non-irritated, non-irradiated, non-hairy skin on torso or upper arm, removing after 72 hours and siting replacement patch on a different area (avoid using the same area for several days).",
                "html": "<p>For <i>patches</i>, apply to dry, non-irritated, non-irradiated, non-hairy skin on torso or upper arm, removing after 72&#8239;hours and siting replacement patch on a different area (avoid using the same area for several days).</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion, injection solution may be diluted in Glucose 5% or Sodium Chloride 0.9%.",
                "html": "<p>For <i>intravenous infusion</i>, injection solution may be diluted in Glucose 5% or Sodium Chloride 0.9%.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion(Sublimaze), give continuously or intermittently in Glucose 5% or Sodium Chloride 0.9%.",
                "html": "<p>For <i>intravenous infusion</i>(<i>Sublimaze</i>), give continuously or intermittently in Glucose 5% or Sodium Chloride 0.9%.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With buccal use in adults",
                    "html": "With <ph outputclass=\"route\">buccal</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "buccal"
                    ]
                },
                "textContent": "For buccal films, moisten mouth, place film on inner lining of cheek (pink side to cheek), hold for at least 5 seconds until it sticks, and leave to dissolve (15&#8211;30 minutes); if more than 1 film required do not overlap, but use another area of the mouth. Avoid liquids for 5 minutes after application; avoid food until the film has dissolved.",
                "html": "<p>For buccal films, moisten mouth, place film on inner lining of cheek (pink side to cheek), hold for at least 5&#8239;seconds until it sticks, and leave to dissolve (15&#8211;30 minutes); if more than 1 film required do not overlap, but use another area of the mouth. Avoid liquids for 5&#8239;minutes after application; avoid food until the film has dissolved.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With buccal use",
                    "html": "With <ph outputclass=\"route\">buccal</ph> use",
                    "routes": [
                        "buccal"
                    ]
                },
                "textContent": "Patients should be advised to place the lozenge in the mouth against the cheek and move it around the mouth using the applicator; each lozenge should be sucked over a 15 minute period. In patients with a dry mouth, water may be used to moisten the buccal mucosa. Patients with diabetes should be advised each lozenge contains approximately 2 g glucose.",
                "html": "<p>Patients should be advised to place the lozenge in the mouth against the cheek and move it around the mouth using the applicator; each lozenge should be sucked over a 15&#8239;minute period. In patients with a dry mouth, water may be used to moisten the buccal mucosa. Patients with diabetes should be advised each lozenge contains approximately 2&#8239;g glucose.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "specificity": {
                    "textContent": "With transdermal use",
                    "html": "With <ph outputclass=\"route\">transdermal</ph> use",
                    "routes": [
                        "transdermal"
                    ]
                },
                "textContent": "Prescriptions for fentanyl patches can be written to show the strength in terms of the release rate and it is acceptable to write 'Fentanyl 25 patches&#8216; to prescribe patches that release fentanyl 25 micrograms per hour. The dosage should be expressed in terms of the interval between applying a patch and replacing it with a new one, e.g. 'one patch to be applied every 72 hours'. The total quantity of patches to be supplied should be written in words and figures.",
                "html": "<p>Prescriptions for fentanyl patches can be written to show the strength in terms of the release rate and it is acceptable to write <i>'Fentanyl 25 patches</i>&#8216; to prescribe patches that release fentanyl 25&#8239;micrograms per hour. The dosage should be expressed in terms of the interval between applying a patch and replacing it with a new one, e.g. <i>'one patch to be applied every 72 hours'</i>. The total quantity of patches to be supplied should be written in words and figures.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/fentanyl-lozenges-for-pain",
                        "label": "www.medicinesforchildren.org.uk/fentanyl-lozenges-for-pain"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Fentanyl lozenges for pain",
                "textContent": "www.medicinesforchildren.org.uk/fentanyl-lozenges-for-pain",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/fentanyl-lozenges-for-pain\">www.medicinesforchildren.org.uk/fentanyl-lozenges-for-pain</xref>\n</p>"
            },
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/fentanyl-patches-for-pain",
                        "label": "www.medicinesforchildren.org.uk/fentanyl-patches-for-pain"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Fentanyl patches for pain",
                "textContent": "www.medicinesforchildren.org.uk/fentanyl-patches-for-pain",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/fentanyl-patches-for-pain\">www.medicinesforchildren.org.uk/fentanyl-patches-for-pain</xref>\n</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "specificity": {
                    "textContent": "With transdermal use",
                    "html": "With <ph outputclass=\"route\">transdermal</ph> use",
                    "routes": [
                        "transdermal"
                    ]
                },
                "textContent": "Patients and carers should be informed about safe use, including correct administration and disposal, strict adherence to dosage instructions, and the symptoms and signs of opioid overdosage.\n\nPatches should be removed immediately in case of breathing difficulties, marked drowsiness, confusion, dizziness, or impaired speech, and patients and carers should seek prompt medical attention.",
                "html": "<p>Patients and carers should be informed about safe use, including correct administration and disposal, strict adherence to dosage instructions, and the symptoms and signs of opioid overdosage.</p><p>Patches should be removed immediately in case of breathing difficulties, marked drowsiness, confusion, dizziness, or impaired speech, and patients and carers should seek prompt medical attention.</p>"
            },
            {
                "type": "generalPatientAdvice",
                "specificity": {
                    "textContent": "With buccal use in adults",
                    "html": "With <ph outputclass=\"route\">buccal</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "buccal"
                    ]
                },
                "textContent": "Patients or carers should be given advice on how to administer fentanyl buccal films or fentanyl lozenges.",
                "html": "<p>Patients or carers should be given advice on how to administer fentanyl buccal films or fentanyl lozenges.</p>"
            },
            {
                "type": "generalPatientAdvice",
                "specificity": {
                    "textContent": "With intranasal use in adults",
                    "html": "With <ph outputclass=\"route\">intranasal</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intranasal"
                    ]
                },
                "textContent": "Patients or carers should be given advice on how to administer fentanyl nasal spray.",
                "html": "<p>Patients or carers should be given advice on how to administer fentanyl nasal spray.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "solution for injection",
                "solution for infusion",
                "infusion"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77128",
                "label": "Sublingual tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77070",
                "label": "Buccal tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77107",
                "label": "Buccal film",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77055",
                "label": "Lozenge",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77090",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77100",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77115",
                "label": "Transdermal patch",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77076",
                "label": "Spray",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP88071",
                "label": "BUPIVACAINE WITH FENTANYL",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78500",
                "label": "Pre-medication and peri-operative drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78520",
                "label": "Analgesics",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_95",
                "label": "Fentanyl",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34573",
                "label": "OPIOIDS",
                "type": "drugClass"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP107735",
                "label": "Prescribing in palliative care",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77128",
                "label": "Sublingual tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77070",
                "label": "Buccal tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77107",
                "label": "Buccal film",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77055",
                "label": "Lozenge",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77090",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77100",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77115",
                "label": "Transdermal patch",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77076",
                "label": "Spray",
                "type": "medicinalForm"
            }
        ]
    }
}